PH12016502281A1 - Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods for use as ido1 inhibitors - Google Patents

Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods for use as ido1 inhibitors

Info

Publication number
PH12016502281A1
PH12016502281A1 PH12016502281A PH12016502281A PH12016502281A1 PH 12016502281 A1 PH12016502281 A1 PH 12016502281A1 PH 12016502281 A PH12016502281 A PH 12016502281A PH 12016502281 A PH12016502281 A PH 12016502281A PH 12016502281 A1 PH12016502281 A1 PH 12016502281A1
Authority
PH
Philippines
Prior art keywords
pyrrolidine
methods
pharmaceutical compositions
dione derivatives
formula
Prior art date
Application number
PH12016502281A
Inventor
Stefano Crosignani
Sandra Cauwenberghs
Gregory Driessens
Frederik DEROOSE
Original Assignee
Iteos Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BE2014/0754A external-priority patent/BE1021251B1/en
Priority claimed from PCT/IB2015/053557 external-priority patent/WO2015173764A1/en
Application filed by Iteos Therapeutics filed Critical Iteos Therapeutics
Publication of PH12016502281A1 publication Critical patent/PH12016502281A1/en

Links

Abstract

The present invention relates to compound of Formula (I) or pharmaceutically acceptable enantiomers, salts, solvates or prodrugs thereof. The invention further relates to the use of the compounds of Formula (I) as ID01 inhibitors. The invention also relates to the use of the compounds of Formula I for the treatment and/or prevention of cancer and endometriosis. The invention also relates to a process for manufacturing compounds of Formula (I).
PH12016502281A 2014-05-15 2016-11-15 Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods for use as ido1 inhibitors PH12016502281A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201461996976P 2014-05-15 2014-05-15
EP14168534 2014-05-15
BE2014/0754A BE1021251B1 (en) 2014-05-15 2014-10-21 PYRROLIDINE-2,5-DIONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE AS INHIBITORS OF IDO1
PCT/IB2015/053557 WO2015173764A1 (en) 2014-05-15 2015-05-14 Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods for use as ido1 inhibitors

Publications (1)

Publication Number Publication Date
PH12016502281A1 true PH12016502281A1 (en) 2017-02-13

Family

ID=59858293

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12016502281A PH12016502281A1 (en) 2014-05-15 2016-11-15 Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods for use as ido1 inhibitors

Country Status (7)

Country Link
JP (1) JP2017214409A (en)
BR (1) BR112016026346A8 (en)
CL (1) CL2016002899A1 (en)
NI (1) NI201600171A (en)
PH (1) PH12016502281A1 (en)
SV (1) SV2016005317A (en)
ZA (1) ZA201607127B (en)

Also Published As

Publication number Publication date
ZA201607127B (en) 2018-05-30
JP2017214409A (en) 2017-12-07
BR112016026346A2 (en) 2017-08-15
CL2016002899A1 (en) 2017-06-02
NI201600171A (en) 2017-01-03
SV2016005317A (en) 2017-07-10
BR112016026346A8 (en) 2021-07-20

Similar Documents

Publication Publication Date Title
MX2016015005A (en) Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods for use as ido1 inhibitors.
PH12018500061A1 (en) Oxysterols and methods of use thereof
MX2022012313A (en) Oxysterols and methods of use thereof.
MX2016017030A (en) Mnk inhibitors and methods related thereto.
NZ727185A (en) Phosphatidylinositol 3-kinase inhibitors
MX2015012427A (en) Heteroaryl acid morpholinone compounds as mdm2 inhibitors for the treatment of cancer.
MX2020011449A (en) Oxysterols and methods of use thereof.
MX2021014531A (en) Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith.
NZ726608A (en) Phosphatidylinositol 3-kinase inhibitors
MX369369B (en) Quinolone derivatives as fibroblast growth factor receptor inhibitors.
NZ726360A (en) Phosphatidylinositol 3-kinase inhibitors
NZ726638A (en) Phosphatidylinositol 3-kinase inhibitors
PH12014502586A1 (en) Novel ring-substituted n-pyridinyl amides as kinase inhibitors
MY194116A (en) Pharmaceutical compounds
MX2018001992A (en) Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors.
MX362896B (en) Cis-morpholinone and other compounds as mdm2 inhibitors for the treatment of cancer.
PH12016501997B1 (en) Cycloalkyl-linked diheterocycle derivatives
MX2017008074A (en) IMIDAZOPYRIDAZINE DERIVATIVES AS PI3Kß INHIBITORS.
MX2017002544A (en) Isoquinolinone derivatives useful in the treatment of cancer.
PH12016502281A1 (en) Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods for use as ido1 inhibitors
MA39993A (en) Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods for use as ido1 inhibitors
CR20160532A (en) DERIVATIVES OF PIRROLIDINA-2,5-DIONA, PHARMACEUTICAL COMPOSITIONS AND METHODS TO USE AS IDO1 INHIBITORS